METABOLIC & WEIGHT RESEARCH / COLOPHON

About This Research Desk

An independent, citation-grounded digest of the metabolic peptide literature. Not a vendor. Not a clinic. Not medical advice.

What Peptide Supplied is

Peptide Supplied is an independent editorial reference desk covering the published research on three peptides studied for metabolic regulation and weight management: retatrutide, tesamorelin, and MOTS-c, with retatrutide as the lead. The site exists to make a fast-moving, technically dense, and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually tested on, in which species or population, and how far that evidence legitimately extends.

The organizing framework is straightforward: three peptides that approach the same metabolic question from different points in the physiological chain — direct receptor activation, GH-axis stimulation, and mitochondrial energy sensing — so that reading them together gives a more complete picture than any one alone. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source.

How it is compiled

Three principles govern what appears on this site.

First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles, clinical trial reports, and regulatory documents — collected on the references page. Each citation includes a DOI or PubMed link. Where a finding comes from a review rather than a primary study, the review is cited as the source.

Second, evidence is reported at its actual strength. Clinical trial results are reported as published — including the population studied, the dose used, and the duration. Preclinical results are identified as animal or cell studies, not translated to human recommendations. Where approval is narrow (tesamorelin), we say so. Where evidence is entirely preclinical (MOTS-c), we say so. Where a compound is investigational and unapproved (retatrutide), we say so plainly.

Third, the three pages are cross-referenced. Because the same metabolic themes — visceral fat, insulin sensitivity, energy expenditure, GH axis — appear across compounds, the pages link to one another and to the comparison page, so a reader can follow a mechanism or a clinical question across all three.

What it is not

Peptide Supplied is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person, and it never presents an animal-study dose as something a human should use.

The compounds discussed here are research peptides — one is investigational (retatrutide), one is approved for a narrow HIV-related indication only (tesamorelin), and one has no approved use at all (MOTS-c). None is presented here as a treatment, a supplement, or a recommendation. Readers with health questions should consult a licensed clinician in their jurisdiction. The value this site offers is a direct, accurate account of the published research — nothing more, and nothing it pretends to be.